dan 2163 has been researched along with Anochlesia in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The induction of catalepsy in animal models is usually seen as an indicator of the propensity to induce extrapyramidal side effects in patients." | 2.42 | Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. ( Möller, HJ, 2003) |
| "9j exhibited a low potential for catalepsy, consistent with results with risperidone." | 1.43 | Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics. ( Chen, XW; Fu, L; Li, JQ; Sun, YY, 2016) |
| " We found that RG-15 showed a good oral bioavailability (54%) and high brain levels (approx." | 1.35 | Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15. ( Agai Csongor, E; Domány, G; Elekes, O; Gémesi, LI; Gyertyán, I; Kapás, M; Kedves, R; Kiss, B; Laszy, J; Pásztor, G; Sághy, K; Szombathelyi, Z; Zájer-Balázs, M, 2008) |
| "In contrast, MS-377 did not affect the catalepsy induction by these drugs." | 1.31 | Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors. ( Horikomi, K; Karasawa, J; Takagi, K; Takahashi, S, 2002) |
| "The bar test was used to evaluate the catalepsy induced by each drug." | 1.31 | Effect of the amisulpride isomers on rat catalepsy. ( Bartholini, F; Casti, P; Gessa, G; Marchese, G; Pani, L; Ruiu, S; Saba, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XW | 1 |
| Sun, YY | 1 |
| Fu, L | 1 |
| Li, JQ | 1 |
| Gyertyán, I | 1 |
| Sághy, K | 1 |
| Laszy, J | 1 |
| Elekes, O | 1 |
| Kedves, R | 1 |
| Gémesi, LI | 1 |
| Pásztor, G | 1 |
| Zájer-Balázs, M | 1 |
| Kapás, M | 1 |
| Agai Csongor, E | 1 |
| Domány, G | 1 |
| Kiss, B | 1 |
| Szombathelyi, Z | 1 |
| Karasawa, J | 1 |
| Takahashi, S | 2 |
| Takagi, K | 2 |
| Horikomi, K | 2 |
| Marchese, G | 1 |
| Bartholini, F | 1 |
| Ruiu, S | 1 |
| Casti, P | 1 |
| Saba, P | 1 |
| Gessa, G | 1 |
| Pani, L | 1 |
| Möller, HJ | 1 |
| Worms, P | 1 |
| Sonehara, K | 1 |
| Miwa, T | 1 |
| Mita, N | 1 |
| Nagase, H | 1 |
| Iizuka, K | 1 |
| Sakai, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparative Efficacy and Safety of Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in the Treatment of Post Schizophrenic Depression: A Randomized Controlled Trial[NCT04876521] | Phase 4 | 60 participants (Anticipated) | Interventional | 2021-05-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dan 2163 and Anochlesia
| Article | Year |
|---|---|
Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
Topics: Amisulpride; Animals; Antipsychotic Agents; Catalepsy; Dissociative Disorders; Dopamine Antagonists; | 2003 |
6 other studies available for dan 2163 and Anochlesia
| Article | Year |
|---|---|
Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics.
Topics: Amides; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Cognition; Locomotion; Male; Pip | 2016 |
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
Topics: Amisulpride; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Biological Availabi | 2008 |
Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agoni | 2002 |
Effect of the amisulpride isomers on rat catalepsy.
Topics: Amisulpride; Analysis of Variance; Animals; Brain; Catalepsy; Dose-Response Relationship, Drug; Male | 2002 |
Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Catalepsy; Hu | 1982 |
Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Free Radical | 1999 |